Skip to content
healthcare.dev

ivabradine

NDC 70771-1864, ivabradine, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1864
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213442
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1864 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IVABRADINE HYDROCHLORIDE7.5 mg/1

Pharmacologic classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]

Package NDCNDC-11Package
70771-1864-67077118640660 TABLET in 1 BOTTLE (70771-1864-6)
70771-1864-870771186408180 TABLET in 1 BOTTLE (70771-1864-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/246b495a-ea7b-4cbe-9a5f-87c2c0a59cb3

Use it

Look up 70771-1864 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1864 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1864. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.